PRLD · Forms 3, 4, 5
Insider trades at Prelude Therapeutics Inc
No open-market insider buys or sells at Prelude Therapeutics Inc in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Prelude Therapeutics Inc (PRLD) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Prelude Therapeutics Inc in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Director | Options or other derivatives | Form 4 | ||||
| Katina Dorton | Director | Options or other derivatives | Form 4 | ||||
| Martin Babler | Director | Options or other derivatives | Form 4 | ||||
| David P Bonita | Director | Options or other derivatives | Form 4 | ||||
| Victor Sandor | Director | Options or other derivatives | Form 4 | ||||
| Paul A Friedman | Director | Options or other derivatives | Form 4 | ||||
| Charles Q Morris | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| RA CAPITAL MANAGEMENT, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| RA CAPITAL MANAGEMENT, L.P. | 10% owner | Other | 1,407,000 | Form 4 | |||
| David P Bonita | Director | Buy | 1,689,189 | $4.44 | $7.5M | Form 4 | |
| David P Bonita | Director | Buy | 1,126,126 | $4.44 | $5M | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.